title: Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes.
authors.forename: Catherine L
authors.initials: CL
authors.lastname: Carmichael
authors.forename: Ella J
authors.initials: EJ
authors.lastname: Wilkins
authors.forename: Henrik
authors.initials: H
authors.lastname: Bengtsson
authors.forename: Marshall S
authors.initials: MS
authors.lastname: Horwitz
authors.forename: Terence P
authors.initials: TP
authors.lastname: Speed
authors.forename: Paul C
authors.initials: PC
authors.lastname: Vincent
authors.forename: Graham
authors.initials: G
authors.lastname: Young
authors.forename: Christopher N
authors.initials: CN
authors.lastname: Hahn
authors.forename: Robert
authors.initials: R
authors.lastname: Escher
authors.forename: Hamish S
authors.initials: HS
authors.lastname: Scott
mesh_terms: D001483:Base Sequence; D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics*; D005260:Female; D052138:Genes, Neoplasm; D020022:Genetic Predisposition to Disease; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics*; D010375:Pedigree; D011379:Prognosis
chemical_list: D022762:CCAAT-Enhancer-Binding Proteins; C515848:CEBPA protein, human; D009363:Neoplasm Proteins